Starpharma Holdings LimitedASX: SPL

Chair and Deputy Chair Appointments

· Issued by Starpharma Holdings Limited via ASX

Filed with ASX · · 1 page · English

Summary by 6ix AI

Dr. Russell Basser has taken over as Chair, while Mr. David McIntyre has been appointed as Deputy Chair, effective immediately after the recent Annual General Meeting. Mr. Thomas will remain with the company as a non-executive director to ensure a smooth transition.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

On 6ix: 6ix.com/news/chair-and-deputy-chair-appointments-2

Release

ASX Announcement Chair and Deputy Chair Appointments Melbourne, Australia; 6 November 2026: Starpharma (ASX: SPL, US OTC: SPHRY) advises that, as previously announced on 1 October 2026, Mr Rob Thomas AO has retired as Chair following the conclusion of the Company’s 2026 Annual General Meeting,...

Starpharma Holdings Limited on 6ix

In the deck

Earlier from Starpharma

All Starpharma news releases